Skip to main content
SpringerLink
Log in

Transurethrale Vaporisierung der Prostata

  • Chapter
Benigne Prostatahyperplasie

  • 57 Accesses

Zusammenfassung

Die transurethrale Resektion der Prostata (TURP) ist die führende Therapie der benignen Prostatahyperplasie (BPH) und gilt als »Goldstandard«. Bottini nutzte bereits 1876 galvanischen Strom zur Blutungskontrolle [3], doch die Methode konnte sich damals noch nicht durchsetzen. Der kalte Punch wurde - zunächst ohne optische Kontrolle - das Instrument zur TURP. Strom konnte zur Koagulation verwendet werden. Durch die Nutzung von Strom (zunächst galvanisch, später hochfrequent) wurden Schlingen zu Schneideinstrumenten. 1931 wurden von Stern und McCarthy Resektoskope entwickelt, die den hochfrequenten Strom zum Schneiden und Koagulieren verwendeten [22,37]. Dieses Prinzip liegt der TURP bis heute zugrunde.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Babayan RK, Siroky MB, Kranke RJ (1994) Transurethral vaporization of the prostate (TUVP): an electrosurgical alternative to laser prostatectomy. 12th World Congress on Endourology and SWL, 2.-6. Dezember 1994, St. Louis

    Google Scholar 

  2. Blute ML, Tomera KM, Hellerstein DK, McKiel EF, Lynch JH, Regan JB, Sankey NE (1993) Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results from the United States Prostatron Cooperativ Study. J Urol 150:1591–1596

    PubMed  CAS  Google Scholar 

  3. Bottini E (1877) Radicale Behandlung der auf Hypertrophie beruhenden Ischurie. Arch Klin Chir 21:1–24

    Google Scholar 

  4. Bush IM, Malters E, Bush J (1993) Transurethral vaporization of the prostate (TVP): new horizons. Soc Minimally Invasive Ther 2 [suppl]: 98

    Google Scholar 

  5. Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J (1992) Laser ablation of the prostate in patients with benign prostatic hyperthrophy. Br J Urol 69: 603–608

    Article  PubMed  CAS  Google Scholar 

  6. Doli HA, Black NA, McPhreson K, Flood AB, Williams GB, Schmith JC (1992) Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol 147:1566–1573

    Google Scholar 

  7. Ekengren J, Hahn RG (1996) Complications during transurethral vaporization of the prostate. Urology 48/3:424–427

    Article  Google Scholar 

  8. Gibbons RP, McNicholas TA, Koshiba K, Flam T, Jewett MAS, Stein BS, Steg A (1993) Surgical and laser treatment. In: Cockett ATK, Khoury S, Aso Y, ChatelaIn C, Denis L, Griffiths K, Murphy G (eds) The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Proceedings. SCI, Jersey, pp 363–374

    Google Scholar 

  9. Gormley GJ, Stoner E, Bruskewitz RC et al. for the Finasteride Study Group (1992) The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 327:1185–1191

    Article  PubMed  CAS  Google Scholar 

  10. Holtgrewe HL, Valk WL (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 87:450–459

    PubMed  CAS  Google Scholar 

  11. Holtgrewe HL, Mebust WK, DowdJB, Cockett ATK, Peters PC, Proctor C (1989) Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol 141: 248–253

    PubMed  CAS  Google Scholar 

  12. Kabalin JN (1993) Laser prostatectomy performed with a right angle firing neodymium: YAG laser fiber at 40 watts power setting. J Urol 150: 95–99

    PubMed  CAS  Google Scholar 

  13. Kaplan SA, Shabsigh R, Soldo KA, Olsson CA (1993) Transrectal thermal therapy in the management of men with prostatism: an algorithm for therapy. Br J Urol 72:195

    PubMed  CAS  Google Scholar 

  14. Kaplan SA, Te AE (1995) Transurethral electrovaprization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 45: 566–572

    Article  PubMed  CAS  Google Scholar 

  15. Kim CA, Nissar N, de las Morenas A, Babayan RK (1996) Evaluation of electrovaporization techniques in the canine prostate. J Endourol 10: S59

    Article  Google Scholar 

  16. Köhrmann KU, Michel MS, Alken P (1995) Loop, rollerball or vaportrode: an experimental comparison. J Endourol 9: 54

    Google Scholar 

  17. Kramolowsky EV, Tucker RD (1991) The urological application of electrosurgery. J Urol 146: 669–674

    PubMed  CAS  Google Scholar 

  18. Leach GE, Sirls L, Ganabathi K, Roskamp D, Dmochowski R (1994) Outpatient visual laser-assisted prostatectomy under local anesthesia. Urology 43:149–153

    Article  PubMed  CAS  Google Scholar 

  19. Lepor H, Auerbach S, Puras-Baez AG et al. (1992) A randomized placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 148:1467–1474

    PubMed  CAS  Google Scholar 

  20. Leyh H, Fastenmeier K, Barba M, Härtung R (1996) Stromfluß und in den Patienten eingespeiste Leistung bei der transurethtralen Vaporisation der Prostata. Urologe A (Suppl.): 93

    Google Scholar 

  21. Malloy TR, Carpiniello VL, Wein AJ, Payne C, Wuchinich D (1991) Bladder outlet obstruction treated with ultrasonic aspiration: one year follow-up on 59 patients. Urology 37: 512–515

    Article  PubMed  CAS  Google Scholar 

  22. McCarthy JF (1931) A new apparatus for endoscopic plastic surgery of the prostate, diathermia and excision of vesical growth. J Urol 26: 695–696

    Google Scholar 

  23. McLean AJ (1929) The Bovie electrosurgical current generator: some underlying priciples and results. Arch Surg 18:1863–1867

    Google Scholar 

  24. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating instutitions evaluating 3,885 patients. J Urol 141: 243–247

    PubMed  CAS  Google Scholar 

  25. Melchior J, Valk WL, Foret JD, Mebust WK (1974) Transurethral prostatectomy: computerized analysis of 2,223 consecutive cases. J Urol 112: 634–642

    PubMed  CAS  Google Scholar 

  26. Narayan P, Fournier G, Indudhara R, Leidich R, Shinohara K, Ingerman A (1994) Transurethral evaporation of prostate (TUEP) with Nd:YAG laser using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia. Urology 43: 813–820

    Article  PubMed  CAS  Google Scholar 

  27. Narayan P, Tewari A, Croker B, Garzotto M, Mustafa S, Jones T, Perinchery G (1996) Factors affecting size and configuration of electrovaporization lesions in the prostate. Urology 47/5: 679–688

    Article  Google Scholar 

  28. Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor M (1994) The North American experience with the urolume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American Urolume Study Group. Urology 44: 353–362

    CAS  Google Scholar 

  29. Patel A, Fuchs G, Gutierrez-Aceves J, Ryan T (1996) A prospectively randomized study of energy utiliziation during transurethral electrosurgical resection (TURP) and electro-vaporization (TUEVAP). J Endourol 10: S82

    Google Scholar 

  30. Perlmutter AP, Muschter R (1995) Electrosurgical vaporization of the prostate in the canine model. Urology 46: 518–523

    Article  PubMed  CAS  Google Scholar 

  31. Peters CA, Walsh PC (1987) The effect of nafarelin accetate, a luteinizing hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 317:599–604

    Article  PubMed  CAS  Google Scholar 

  32. Roos NP, Wenneberg JE, Malenka DJ et al. (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320:1120–1124

    Article  PubMed  CAS  Google Scholar 

  33. Schweikert HU, Tunn UW (1987) Effects of the aromatase inhibitor testalactone on human benign prostatic hyperplasia. Steroids 50:191–200

    Article  PubMed  CAS  Google Scholar 

  34. Senge T, Thorwest C, Haupt G (1996) Energy consumption: vaporization versus TURP.J Endourol 10: S82

    Google Scholar 

  35. Sirls LT, Ganabathi K, Zimmern PE, Roskamp DA, Wolde-Tsadik G, Leach GE (1993) Transurethral incision of the prostate: an objective and subjective evaluation of longterm efficacy. J Urol 150: 1615–1621

    PubMed  CAS  Google Scholar 

  36. Smith PH, Marberger M, Conort P et al. (1993) Other non-medical therapies (excluding lasers) in the treatment of BPH. In: Cockett ATK, Khoury S, Aso Y, ChatelaIn C, Denis L, Griffiths K, Murphy G (eds) The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Proceedings. SCI, Jersey, pp 453–491

    Google Scholar 

  37. Stern M (1933) The Stern-method of prostatic resection: the improved resectoscope. Urol Cutan Rev 37: 7–14

    Google Scholar 

  38. Stewart SC, Benjamin D, Weil D, Ruckle HC, Hadley R, Lui PD (1995) Electrovaporization of the prostate: a pilot study. J Urol 153:437

    Article  Google Scholar 

  39. Stewart S, Benjamin D, Ruckle H, Lui P, Hadley R (1995) Transurethral electrovaporization of the prostate: a new technique for the treatment of symptomatic BPH.J Endourol 9:413–6

    Article  PubMed  CAS  Google Scholar 

  40. Stone NN (1989) Flutamide in treatment of benign prostatic hypertrophy. Urology 34 [suppl 4]: 64–68.

    Article  PubMed  CAS  Google Scholar 

  41. Te AE, Kaplan SA (1995) Transurethral electrovaporization of the prostate (TVP): an electrosurgical advancement of the Standard TURP.Curr Surg Tech Urol 8:1–8

    Google Scholar 

  42. Te AE, Reis R, Kaplan SA (1995) TVP: a new modification of TURP.Contemp Urol 7: 74–83

    PubMed  CAS  Google Scholar 

  43. Te AE, Kaplan SA (1996) Electrovaporization of the prostate. Curr Opin Urol 6:2–9

    Article  Google Scholar 

  44. Wolf JS, Rayala HJ, Humphrey PA, Clayman RV (1996) In vivo comparison of electrosurgical »vaporization« electrodes. J Endourol 10: S60

    Google Scholar 

Download references

Authors
  1. G. Haupt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Senge
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    Klaus Höfner , Udo Jonas  & Christian G. Stief ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Haupt, G., Senge, T. (2000). Transurethrale Vaporisierung der Prostata. In: Höfner, K., Jonas, U., Stief, C.G. (eds) Benigne Prostatahyperplasie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59580-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59580-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64034-6

  • Online ISBN: 978-3-642-59580-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation